Progesterone antagonists block the growth of experimental mammary tumors in G0/G1

This publication has 11 references indexed in Scilit:

• Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: Mechanistic studies
  Breast Cancer Research and Treatment, 1989
• ANTIPROGESTINS, A NEW FORM OF ENDOCRINE THERAPY FOR HUMAN-BREAST CANCER
  1989
• Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat
  European Journal of Cancer and Clinical Oncology, 1989
• EFFECT ON GROWTH AND CELL-CYCLE KINETICS OF ESTRADIOL AND TAMOXIFEN ON MCF-7 HUMAN-BREAST CANCER-CELLS GROWN-INVITRO AND IN NUDE-MICE
  1989
• Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
  New England Journal of Medicine, 1989
• The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death
  Journal of Steroid Biochemistry, 1989
• EVALUATION OF A MODELING SYSTEM FOR S-PHASE ESTIMATION IN BREAST-CANCER BY FLOW-CYTOMETRY
  1987
• Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.
  1985
• Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.
  Journal of Cell Biology, 1982
• NEOPLASTIC TRANSFORMATION AND DEFECTIVE CONTROL OF CELL-PROLIFERATION AND DIFFERENTIATION
  1982